Mesoblast (MESO) has had the highest return between September 10, 2007 and October 13, 2026 by a US stock, returning 14,269,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
Mesoblast (MESO) | 9/10/2007 - 10/13/2026 | 14,269,900% |
QXO (QXO) | 9/10/2007 - 10/13/2026 | 3,546,566.67% |
Avita Medical (RCEL) | 9/10/2007 - 10/13/2026 | 3,342,400% |
OPTIMIZERx (OPRX) | 9/10/2007 - 10/13/2026 | 2,054,900% |
Metalla Royalty & Streaming (MTA) | 9/10/2007 - 10/13/2026 | 949,900% |
Fractyl Health, Inc Common Stock (GUTS) | 9/10/2007 - 10/13/2026 | 629,900% |
CleanSpark (CLSK) | 9/10/2007 - 10/13/2026 | 514,900% |
Integra Resources (ITRG) | 9/10/2007 - 10/13/2026 | 511,900% |
Seaport Therapeutics, Inc Common Stock (SPTX) | 9/10/2007 - 10/13/2026 | 171,400% |
Addex Therapeutics (ADXN) | 9/10/2007 - 10/13/2026 | 168,788.89% |
ACCESS Newswire (ACCS) | 9/10/2007 - 10/13/2026 | 168,418.52% |
A2Z Smart Technologies (AZ) | 9/10/2007 - 10/13/2026 | 154,764.86% |
Fubotv (FUBO) | 9/10/2007 - 10/13/2026 | 145,566.67% |
Immatics (IMTX) | 9/10/2007 - 10/13/2026 | 144,100% |
Altimmune (ALT) | 9/10/2007 - 10/13/2026 | 134,636.84% |
VerifyMe (VRME) | 9/10/2007 - 10/13/2026 | 108,671.93% |
MDxHealth (MDXH) | 9/10/2007 - 10/13/2026 | 67,000% |
Lexaria Bioscience (LEXX) | 9/10/2007 - 10/13/2026 | 66,634.69% |
Evogene (EVGN) | 9/10/2007 - 10/13/2026 | 55,614.29% |
Jade Biosciences (JBIO) | 9/10/2007 - 10/13/2026 | 53,746.15% |
LiveOne (LVO) | 9/10/2007 - 10/13/2026 | 51,700% |
Xcel Brands (XELB) | 9/10/2007 - 10/13/2026 | 45,320% |
Cementos Pacasmayo SAA ADR (CPAC) | 9/10/2007 - 10/13/2026 | 41,074.5% |
Cocrystal Pharma (COCP) | 9/10/2007 - 10/13/2026 | 37,757.14% |
BioLife Solutions (BLFS) | 9/10/2007 - 10/13/2026 | 35,000% |